{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:28:02Z","timestamp":1761514082102,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":37,"publisher":"Springer New York","isbn-type":[{"type":"print","value":"9781493969807"},{"type":"electronic","value":"9781493969814"}],"license":[{"start":{"date-parts":[[2017,10,7]],"date-time":"2017-10-07T00:00:00Z","timestamp":1507334400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-1-4939-6981-4_24","type":"book-chapter","created":{"date-parts":[[2017,10,6]],"date-time":"2017-10-06T07:47:46Z","timestamp":1507276066000},"page":"305-329","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Protocol for the Production of a Vaccine Against Argentinian Hemorrhagic Fever"],"prefix":"10.1007","author":[{"given":"Ana Mar\u00eda","family":"Ambrosio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauricio Andr\u00e9s","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea Soledad","family":"Maiza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graciela Susana","family":"Gamboa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebasti\u00e1n Edgardo","family":"Fossa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejando Javier","family":"Bottale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,7]]},"reference":[{"key":"24_CR1","unstructured":"Arribalzaga RA (1955) Una nueva enfermedad epidemica a germen desconocido: hipertermia nefrotoxica, leucopenia, y enantemica. Dia Medico 27"},{"key":"24_CR2","first-page":"567","volume":"52","author":"JI Maiztegui","year":"1975","unstructured":"Maiztegui JI (1975) Clinical and epidemiological patterns of Argentine hemorrhagic fever. Bull WHO 52:567\u2013575","journal-title":"Bull WHO"},{"key":"24_CR3","first-page":"149","volume":"37","author":"MS Sabattini","year":"1977","unstructured":"Sabattini MS, Gonzalez LE, D\u00edaz G, Vega VR (1977) Infecci\u00f3n natural y experimental de roedores con virus Jun\u00edn. Medicina (Buenos Aires) 37:149\u2013161","journal-title":"Medicina (Buenos Aires)"},{"key":"24_CR4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/BF02122437","volume":"175","author":"J Maiztegui","year":"1986","unstructured":"Maiztegui J, Feuillade M, Briggiler A (1986) Progressive extension of the endemic area and changing incidence of Argentine hemorrhagic fever. Med Microbiol Immunol 175:149\u2013152","journal-title":"Med Microbiol Immunol"},{"key":"24_CR5","first-page":"79","volume":"134","author":"MC Weissenbacher","year":"1987","unstructured":"Weissenbacher MC, Laguens RP, Coto CE (1987) Argentine hemorrhagic fever. Curr Top Microbiol Immunol 134:79\u2013116","journal-title":"Curr Top Microbiol Immunol"},{"key":"24_CR6","first-page":"5","volume":"134","author":"CJ Peters","year":"1987","unstructured":"Peters CJ, Jahrling PB, Liu CT, Kenyon RH, McKee KT Jr, Barrera Oro JG (1987) Experimental studies of arenaviral hemorrhagic fevers. Curr Top Microbiol Immunol 134:5\u201368","journal-title":"Curr Top Microbiol Immunol"},{"key":"24_CR7","doi-asserted-by":"publisher","first-page":"554","DOI":"10.4269\/ajtmh.1994.51.554","volume":"51","author":"JN Mills","year":"1994","unstructured":"Mills JN, Ellis BA, Childs JE, McKee KT Jr, Maiztegui JI, Peters CJ et al (1994) Prevalence of infection with Junin virus in rodent populations in the epidemic area of Argentine hemorrhagic fever. Am J Trop Med Hyg 51:554\u2013562","journal-title":"Am J Trop Med Hyg"},{"key":"24_CR8","unstructured":"Barrera Oro JG, Eddy G (1977) Seminario Internacional sobre Fiebres Hemorr\u00e1gicas Producidas por Arenavirus Discusi\u00f3n General. Medicina (Buenos Aires) 32:257\u2013259"},{"key":"24_CR9","unstructured":"Barrera Oro JG, Eddy GA (1982) Characteristics of candidate live attenuated Junin virus vaccine. Paper presented at the international conference on comparative virology, Banff, AB"},{"key":"24_CR10","first-page":"118","volume":"25","author":"JG Barrera Oro","year":"1991","unstructured":"Barrera Oro JG, McKee KT (1991) Toward a vaccine against Argentine hemorrhagic fever. Bull PAHO 25:118\u2013126","journal-title":"Bull PAHO"},{"key":"24_CR11","first-page":"239","volume":"263","author":"DA Enr\u00eda","year":"2002","unstructured":"Enr\u00eda DA, Barrera Oro JG (2002) Junin virusvaccines. Curr Top Microbiol Immunol 263:239\u2013264","journal-title":"Curr Top Microbiol Immunol"},{"key":"24_CR12","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1086\/514211","volume":"177","author":"JI Maiztegui","year":"1998","unstructured":"Maiztegui JI, McKee KT Jr, Barrera Oro JG, Harrison LH, Gibbs PH, Feuillade MR et al (1998) Protective efficacy of a live attenuated vaccine against Argentine hemorrhagic fever. J Infect Dis 177:277\u2013283","journal-title":"J Infect Dis"},{"key":"24_CR13","first-page":"329","volume":"65","author":"AM Ambrosio","year":"2005","unstructured":"Ambrosio AM, Riera LM, Saavedra MC, Sottosanti MJ (2005) Ensayo precl\u00ednico de la vacuna candid #1 (fiebre hemorr\u00e1gica Argentina) producida en Argentina. Medicina (Buenos Aires) 65:329\u2013332","journal-title":"Medicina (Buenos Aires)"},{"key":"24_CR14","first-page":"5","volume":"40","author":"AM Ambrosio","year":"2006","unstructured":"Ambrosio AM, Saavedra MC, Riera LM, Fassio RM (2006) La producci\u00f3n nacional de vacuna a virus Jun\u00edn vivo atenuado (candid # 1) anti-fiebre hemorr\u00e1gica Argentina. Acta Bioqu\u00edm Cl\u00edn Latinoam 40:5\u201317","journal-title":"Acta Bioqu\u00edm Cl\u00edn Latinoam"},{"key":"24_CR15","first-page":"215","volume":"70","author":"DA Enr\u00eda","year":"2010","unstructured":"Enr\u00eda DA, Ambrosio AM, Briggiler AM, Feuillade MR, Crivelli E, y Grupo de Estudio de la vacuna contra la fiebre hemorr\u00e1gica argentina (2010) Vacuna contra la fiebre hemorr\u00e1gica Argentina candid #1 producida en La Argentina. Inmunogenicidad y seguridad Medicina (Buenos Aires) 70:215\u2013222","journal-title":"Inmunogenicidad y seguridad Medicina (Buenos Aires)"},{"key":"24_CR16","unstructured":"WHO Expert Committee on Specifications for Pharmaceutical Preparations (2014) WHO technical report series N\u00b0 986, p. 402"},{"key":"24_CR17","unstructured":"Disposici\u00f3n 2819\/04. Buenas Pr\u00e1cticas de Fabricaci\u00f3n para Elaboradores, Importadores\/Exportadores de Medicamentos (2004) Administraci\u00f3n nacional de Medicamentos, Alimentos y Tecnolog\u00eda M\u00e9dica. Instituto Nacional de Medicamentos."},{"key":"24_CR18","volume-title":"Especialidades medicinales","author":"Disposici\u00f3n 705\/2005. Administraci\u00f3n Nacional de Medicamentos, Alimentos y Tecnolog\u00eda M\u00e9dica","year":"2005","unstructured":"Disposici\u00f3n 705\/2005. Administraci\u00f3n Nacional de Medicamentos, Alimentos y Tecnolog\u00eda M\u00e9dica (2005) Especialidades medicinales. Requisitos para la inscripci\u00f3n de vacunas. Presentaci\u00f3n de la documentaci\u00f3n t\u00e9cnica. Establecimientos elaboradores. Informaci\u00f3n Precl\u00ednica-Cl\u00ednica. Formularios."},{"key":"24_CR19","unstructured":"US Pharmacopeia (1231) Water for pharmaceutical purposes. Expert Committee: (PW05) Pharmaceutical Waters 05"},{"issue":"2","key":"24_CR20","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1128\/CMR.11.2.231","volume":"11","author":"DG Baker","year":"1998","unstructured":"Baker DG (1998) Natural pathogens of laboratory mice, rats, and rabbits and their effects on research. Microbiol Rev 11(2):231\u2013266","journal-title":"Microbiol Rev"},{"key":"24_CR21","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/0003-2697(88)90480-0","volume":"171","author":"RJ Hay","year":"1998","unstructured":"Hay RJ (1998) The seed stock concept and quality control for cell lines. Anal Biochem 171:225\u2013237","journal-title":"Anal Biochem"},{"key":"24_CR22","unstructured":"Coecke, S. et al. (2005) Guidance on good cell culture practice. ATLA 33:261\u2013287. Available in the best practices (GCCP) on the ESACT-UK The UK Society for Cell Culture Biotechnology. \n                    http:\/\/www.esactuk.org.uk\/"},{"key":"24_CR23","unstructured":"World Health Organization (2010) Recommendations for the evaluation of animal cell cultures as substrates for the manufacture of biological medicinal products and for the characterization of cell banks. Proposed replacement of TRS 878, Annex 1"},{"key":"24_CR24","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/BF02619056","volume":"8","author":"RE Wallace","year":"1973","unstructured":"Wallace RE et al (1973) Development of a diploid cell line from fetal rhesus monkey lung for virus vaccine production. In Vitro 8:323\u2013332","journal-title":"In Vitro"},{"key":"24_CR25","first-page":"132","volume-title":"ATCC Quality control methods for cell lines","year":"1992","unstructured":"Hay RJ, Caputo J, Macy ML (eds) (1992) ATCC Quality control methods for cell lines, 2nd edn. ATCC, Rockville, MD, p 132","edition":"2"},{"key":"24_CR26","unstructured":"Guidance for Industry. Characterization and Qualification of Cell Substrates and Other Biological Materials Used in the Production of Viral Vaccines for Infectious Disease Indications (2010) U.S. Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research. View at \n                    http:\/\/www.fda.gov\/BiologicsBloodVaccines\/GuidanceComplianceRegulatoryInformation\/Guidances\/default.htm"},{"key":"24_CR27","unstructured":"Office of the Federal Register, Code of Federal Regulations (2016) 21 CFR part 610.12 (a) to (e).eCFR, 29 Mar 2016"},{"key":"24_CR28","unstructured":"FDA, CFR-Code of Federal Regulations (1998) Title 21, Part 610 \u2013 General Biological Products Standards, Subpart D \u2013 Mycoplasma, Section 610.30, Test for Mycoplasma"},{"key":"24_CR29","unstructured":"VICH GL34: biologicals: testing for the detection of mycoplasma contamination. EMA\/CVMP\/VICH\/463\/2002. Committee for Medicinal Products for Veterinary Use (CVMP), Mar 2013"},{"key":"24_CR30","unstructured":"International conference on harmonization of technical requirements for registration of pharmaceuticals for human use. ICH harmonized tripartite guideline. Viral safety evaluation of biotechnology products derived from cell lines of human or animal origin q5a(r1). Sept 1999"},{"key":"24_CR31","unstructured":"Administraci\u00f3n Nacional de Medicamentos, Alimentos y Tecnolog\u00eda M\u00e9dica. Farmacopea argentina (2013) 7\u00b0 edn, Buenos Aires"},{"key":"24_CR32","unstructured":"FDA, draft guidance for industry: process validation: general principles and practices (Nov 2008). \n                    http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM070336.pdfe\n                    \n                  . Accessed 29 Apr 2016"},{"key":"24_CR33","unstructured":"FDA, CFR-Code of Federal Regulations (1998) Title 21, part 610 \u2013 general biological products standards, Section 610.11"},{"key":"24_CR34","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.3181\/00379727-130-33711","volume":"130","author":"P Webb","year":"1969","unstructured":"Webb P, Johnson K, Mackenzie R (1969) The measurement of specific antibodies in Bolivian hemorrhagic fever by neutralization of virus plaques. Proc Soc Exp Biol Med 130:1013\u20131019","journal-title":"Proc Soc Exp Biol Med"},{"key":"24_CR35","first-page":"493","volume":"27","author":"LJ Reed","year":"1938","unstructured":"Reed LJ, Muench HA (1938) A simple method of estimating fifty per cent endpoints. Am J Hyg 27:493\u2013497","journal-title":"Am J Hyg"},{"key":"24_CR36","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/0166-0934(90)90009-5","volume":"29","author":"G Barrera OroJ","year":"1990","unstructured":"Barrera OroJ G, McKee KT Jr, Spisso J, Mahlandt BG, MaizteguiJI (1990) A refined complement-enhanced neutralization test for detecting antibodies to Junin virus. J Virol Methods 29:71\u201380","journal-title":"J Virol Methods"},{"key":"24_CR37","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1128\/AAC.23.5.649","volume":"23","author":"MJ Case","year":"1983","unstructured":"Case MJ, Ryther SS, Novitsky TJ (1983) Detection of endotoxin in antibiotic solutions with Limulus amoebocyte lysate. Antimicrob Agents Chemother 23:649\u2013652","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Methods in Molecular Biology","Hemorrhagic Fever Viruses"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-6981-4_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T02:53:03Z","timestamp":1558061583000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-6981-4_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,7]]},"ISBN":["9781493969807","9781493969814"],"references-count":37,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-6981-4_24","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2017,10,7]]},"assertion":[{"value":"7 October 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}